Program	No. of Patients	Patient Survival
		Overall	ISB	SB-L	MV
Pittsburgh Abu-Elmagd 200112	155	Actuarial 1 yr 75% 5 yr 54% 10 yr 42%
Miami Kato 200214	110	6 mos 1 yr period I 53% Period II 79% Period III 89% 43% 66% ongoing
Nebraska Langnas 200215	106	2 yr 70%	2 yr 82%	2 yr 60%
New York Fishbein 200216	34	Actuarial 1 yr 74%	Actuarial 1 yr 87%	Actuarial 1 yr 63%
UCLA Farmer 200217	19	Overall 1 yr 67% 3 yr 60% After 1995 1 yr 73% 3 yr 64%
Paris Goulet 200218 (Ped)	36		Actuarial 6 mos, 1 yr, 3 yr 77%	Actuarial 6 mos, 1 yr, 3 yr 74%
UK (Ped)20 Beath 2002	21	1 yr 61% 2 yr 50%
Ontario (Feateau 01) (Ped)21	13	Actual 1 yr 61%	Actual 1 yr 83%	Actual 1 yr 50%	Actual 1 yr 33%
Intestinal Tx Registry Grant 1999	651	1 year 63% 3 year 51% As of May 2001 335/651 patients survived Survival rate 51.5%	Mar 1995 - 1997 1 yr 69%	Mar 1995 - 1997 1 yr 66%	Mar 1995 - 1997 1 yr 63%